Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2010
05/20/2010WO2010035259A3 Compositions comprising soluble cd84 or anti-cd84 antibodies and methods for diagnosing and treating b-cll
05/20/2010WO2010033993A3 Correlation of molecular markers with clinical outcome in gbm patients radiation treated with or without gefitinib
05/20/2010WO2010033724A3 Particle-containing membrane and particulate electrode for analyte sensors
05/20/2010WO2010033267A3 Structures, methods of making structures, multi-well array surface enhanced raman spectroscopy (sers) chips, methods of making, and methods of use
05/20/2010WO2010032245A3 Means and methods for detecting bacteria in an aerosol sample
05/20/2010WO2010032001A8 Sensor
05/20/2010WO2010030189A9 Fluid analysis system and method for operation of an analysis system
05/20/2010WO2010027812A3 Microfluidic systems incorporating flow-through membranes
05/20/2010WO2010027642A3 Selecting for cooperatively interacting molecules
05/20/2010WO2010027446A3 Synaptic vesicle cycling assays and systems
05/20/2010WO2010025393A3 Protein biomarkers and methods for diagnosing kawasaki disease
05/20/2010WO2010020647A3 New method for identifying compounds useful for treating and/or preventing disease-associated with bone loss
05/20/2010WO2010017473A3 Method of identifying ikk2 activators or inhibitors
05/20/2010WO2010017257A3 Psa and klk2 as therapeutic targets and molecules inhibiting psa and klk2
05/20/2010WO2010015376A8 Method for determining sumoylation
05/20/2010WO2010011315A3 Proteins for use in diagnosing and treating infection and disease
05/20/2010WO2010009440A3 Non-invasive fetal rhd genotyping from maternal whole blood
05/20/2010WO2009156343A3 Hand-held analysis appliance for analysing a body fluid, and method for controlling said appliance
05/20/2010WO2009154860A3 Cripto-1 as a biomarker for cardiac hypoxia
05/20/2010WO2009151693A3 Imaging mass spectrometry for improved prostate cancer diagnostics
05/20/2010WO2009133197A3 Levels of april in serum and use in diagnostic methods
05/20/2010WO2009106073A3 Mhc multimers in borrelia diagnostics and disease
05/20/2010US20100125917 TRANSGENIC NON-HUMAN MAMMAL WITH AN ONCOGENIC MUTANT OF THE c-Raf-1 GENE
05/20/2010US20100125420 Food content detector
05/20/2010US20100125419 Food content detector
05/20/2010US20100125418 Food content detector
05/20/2010US20100125417 Food content detector
05/20/2010US20100125131 Gene Encoding A Guanine Nucleotide Exchange Factor And The Gene Product Thereof
05/20/2010US20100125092 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
05/20/2010US20100125090 Modulators of ATP-Binding Cassette Transporters
05/20/2010US20100124790 Portable optical biosensor measuring apparatus and measurement method thereof
05/20/2010US20100124789 Electronic detection of interaction and detection of interaction based on the interruption flow
05/20/2010US20100124786 Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of use Thereof for Diagnosis of Ovarian Cancer
05/20/2010US20100124785 Wild-card-modification technique for peptide identification
05/20/2010US20100124762 Fluidized bed detector for continuous, ultra-sensitive detection of biological and chemical materials
05/20/2010US20100124756 Collection of biomarkers for diagnosis and monitoring of alzheimer's disease in body fluids
05/20/2010US20100124755 Prostate cancer and melanoma antigens
05/20/2010US20100124754 Cloning, Expression And Purification Of Recombinant Porcine Intrinsic Factor For Use In Diagnostic Assay
05/20/2010US20100124750 Analyzing methods and devices for biological reactions between a liquid phase and a solid phase
05/20/2010US20100124555 Compositions and Methods for Treating Pancreatic Tumors
05/20/2010US20100124552 Peptide biomarkers of cardiovascular disease
05/20/2010US20100124529 Method of manufacturing carbon cylindrical structures and biopolymer detection device
05/20/2010US20100124517 Device for performing rapid 'on-site' tests of biological fluids
05/20/2010US20100123456 Method for influencing and/or detecting magnetic particles in a region of action, magnetic particles and the use of magnetic particles
05/20/2010US20100122590 Device for sampling metal melts
05/20/2010US20100122568 Gas sensor system and method for controlling gas sensor
05/20/2010DE4414679B4 Verfahren zur Bestimmung des Oxigenisierungsgrades eines Objektes A method for determining an object of the Oxigenisierungsgrades
05/20/2010DE102008058132A1 Gerät und Verfahren zur Auswertung und Bewertung eines Teststreifens Apparatus and method for analysis and evaluation of a test strip
05/20/2010DE102008058088A1 Verfahren zur räumlich hochauflösenden Untersuchung einer mit einer Substanz markierten Struktur einer Probe Method for high spatial resolution examination of a labeled substance with a structure of a sample
05/20/2010DE102008057842A1 Monitoring device for monitoring e.g. lubricant data of internal combustion engine in motor vehicle, has data transmission unit set in connection with base station, which includes receiving unit to receive data from data transmission unit
05/20/2010DE102008057451A1 Verfahren zur oralen Vakzinierung mittels rekombinanter Hefen Method for oral vaccination using recombinant yeast
05/20/2010DE102008057257A1 Collecting oral mucosal cells and/or -cell fragments from patients, comprises allowing patient to chew a water-insoluble, indigestible chewing mass, during which cells are absorbed in chewing mass and separating the cells from chewing mass
05/20/2010DE102008057086A1 Gassensoreinrichtung zur Bestimmung menschlicher Aktivität und Anwesenheit Gas sensor device for determining the presence of human activity and
05/20/2010DE102008057067A1 Apparatus for parallel micro-array experiments, e.g. in DNA analysis, has a micro-titration plate with reaction vessels and a micro-array to one side of them
05/20/2010DE102008054345A1 Method for detecting biological agent and other dangerous substances, involves adapting model of substances to measured data, and transmitting model to transportable units such that substances are detected
05/20/2010DE102008039624B4 MIP-Nanopartikel-Chipsensor, dessen Verwendung und analytisches Nachweisverfahren MIP nanoparticles-chip sensor, its use and analytical detection methods
05/20/2010DE102006005574B4 Meßvorrichtung zur Bestimmung der Größe, Größenverteilung und Menge von Partikeln im nanoskopischen Bereich Measuring device for determining the size, size distribution and quantity of particles in the nanoscopic range
05/20/2010CA2794757A1 Methods for prediction of inflammatory bowel disease (ibd) using serologic markers
05/20/2010CA2744029A1 Method of analyzing a composition containing impurities
05/20/2010CA2743925A1 Methods for identifying modulating compounds of lymphangiogenesis, means therefore, compounds and uses thereof
05/20/2010CA2743853A1 Novel hiv-2 isolate
05/20/2010CA2743830A1 Collection tubes apparatus, systems, and methods
05/20/2010CA2743660A1 Vaccine strains of brachyspira hyodysenteriae
05/20/2010CA2743590A1 Diagnosis of multiple sclerosis
05/20/2010CA2743485A1 Thyroid analyte detection and measurement
05/20/2010CA2743473A1 Methods and compositions of molecular profiling for disease diagnostics
05/20/2010CA2743464A1 Therapeutic and diagnostic methods relating to cancer stem cells
05/20/2010CA2743305A1 Anti-cxcr1 compositions and methods
05/20/2010CA2743282A1 Simultaneous measurment of the in vivo metabolism of isoforms of a biomolecule
05/20/2010CA2743258A1 Biocompatible electrode
05/20/2010CA2743211A1 Methods and systems of using exosomes for determining phenotypes
05/20/2010CA2742804A1 Fluorescent neutralization and adherence inhibition assays
05/20/2010CA2742784A1 Oximeter device
05/20/2010CA2742771A1 Modification of amyloid-beta load in non-brain tissue
05/20/2010CA2742286A1 Pacap as a marker for cancer
05/20/2010CA2741801A1 Insoluble carrier for use in anti-phospholipid antibody measurement reagent, anti-phospholipid antibody measurement reagent, and method for measuring anti-phospholipid antibody
05/20/2010CA2741276A1 Combined use of bendamustine, doxorubicin and bortezomib for the treatment of multiple myeloma
05/19/2010EP2187217A1 Detection method of gynecologic cancer
05/19/2010EP2187216A1 Novel liver cancer marker
05/19/2010EP2187215A1 Histomonas meleagridis assay
05/19/2010EP2187214A1 Method for measuring inhibitory activity on ligand-receptor binding
05/19/2010EP2187213A1 Method for detecting interactions between two and more biological macromolecules
05/19/2010EP2187212A1 Method for spatial high-resolution investigation of a structure of a sample marked with a substance
05/19/2010EP2187211A1 Diagnosis of diseases by measuring chemokinesis
05/19/2010EP2187210A1 Measurement device for body fluid analysis
05/19/2010EP2187209A1 Hemolyser
05/19/2010EP2187208A1 Method for concentration of low-molecular-weight proteins and peptides in body fluid sample
05/19/2010EP2187201A1 Cartridge device for blood analysis
05/19/2010EP2187198A1 Blood examination apparatus
05/19/2010EP2187196A2 Device for determining the hot crack sensitivity of metallic melts
05/19/2010EP2187194A2 Device for taking a sample from metal melts
05/19/2010EP2186913A2 Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
05/19/2010EP2186910A2 Methods and compositions for improved luminescence assays using microparticles
05/19/2010EP2186901A2 Mutations in the BCR-Abl-tyrosine kinase associated with resistance to STI-571
05/19/2010EP2186896A1 Cancer antigen peptides derived from WT1
05/19/2010EP2186895A1 Method for detecting and quantifying endogenous wheat DNA sequence
05/19/2010EP2186894A1 Monoclonal antibody having neutralizing activity against mmp13
05/19/2010EP2186884A2 HCV-anti-core monoclonal antibody
05/19/2010EP2186879A2 High sensitivity quantitation of peptides by mass spectrometry
05/19/2010EP2186567A1 Device and methods for collection of biological fluidsample and treatment of selected components